AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...
AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...
In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer's ...
An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...
In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...
RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...
Scientists used a special imaging technique to observe how Tau protein clumps in the brain tissue of genetically modified ...
(IN BRIEF) An international team of researchers has made a significant breakthrough in Alzheimer’s drug development with the introduction of RI-AG03, a novel peptide inhibitor that targets and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results